Company intelligence / Profile preview

Solana Biosciences

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Solana Biosciences was a San Diego-based biotechnology company specializing in the development of next-generation sequencing (NGS) technologies. Founded by industry veterans from companies like Illumina and Affymetrix, the firm focused on creating innovative chemistry and library preparation solutions to improve sequencing efficiency. In January 2019, Solana Biosciences was acquired by MGI Tech, a subsidiary of BGI Group, to strengthen MGI's portfolio of high-throughput sequencing instruments. The acquisition integrated Solana's proprietary technologies into MGI's global genomics platform, enhancing its competitive edge in the life sciences market. The company's expertise in molecular biology and genomic workflows continues to influence MGI's product development.

Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Solana Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solana Biosciences.

Explore the full profile